Lawrence P. Guiheen

Director, ADMA Biologics (United States).

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 17, 2026Gift 30,000 shares of ADMA Biologics (United States)²
Mar 17, 2026Gift 30,000 shares of ADMA Biologics (United States)²
Mar 13, 2026Exercised options 30,000 shares at $3.66 of ADMA Biologics (United States)²
Feb 9, 2026Granted 10,690 shares of ADMA Biologics (United States)³
Jun 9, 2025Sold 20,000 shares at $20.96 of ADMA Biologics (United States)⁴
May 22, 2025Sold 1,221 shares at $20.12 of ADMA Biologics (United States)⁵
May 22, 2025Exercised options 1,221 shares at $5.96 of ADMA Biologics (United States)⁵
May 21, 2025Sold 7,779 shares at $20.32 of ADMA Biologics (United States)⁵
May 21, 2025Exercised options 7,779 shares at $5.96 of ADMA Biologics (United States)⁵
Feb 19, 2025Granted 10,889 shares of ADMA Biologics (United States)⁶
Sep 9, 2024Sold 9,000 shares at $18.47 of ADMA Biologics (United States)⁷
Sep 9, 2024Exercised options 9,000 shares at $10.80 of ADMA Biologics (United States)⁷
Feb 26, 2024Granted 24,040 shares of ADMA Biologics (United States)⁸
Mar 6, 2023Granted 25,815 shares of ADMA Biologics (United States)⁹
Mar 7, 2022Granted 26,586 shares of ADMA Biologics (United States)¹⁰

The numbers on this page point here. Each one links to the record it came from.